SARS-CoV-2
Conditions
Keywords
SARS-CoV-2, Covid-19, Solid Organ transplantation, Incidence, Prognosis, Cellular response, Humoral Response
Brief summary
Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population
Interventions
None listed
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a confirmed SARS-CoV-2 infection * Adult and pediatric
Exclusion criteria
\- There are no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Presentation and Incidence of Covid-19 Infection in Different Cohorts of Solid Organ Transplant Patients | From 1st March 2020 to 1st March 2021 |
Countries
France
Contacts
Primary ContactSophie CAILLARD, MD, PhD
Backup ContactSaïd CHAYER, PhD, HDR
Outcome results
None listed